Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06867809 · ClinicalTrials.gov registry record · NA

Spine and Brain Stimulation for Movement Recovery After Cervical Spinal Cord Injury

A NA study of Spinal Cord Injury and Spinal Cord Injury Cervical, sponsored by Jason Carmel.

Recruiting
Registry status
NA
Development phase
20
Enrollment target
2
Study locations

NCT06867809: Recruiting NA study of Spinal Cord Injury and Spinal Cord Injury Cervical, sponsored by Jason Carmel.

NCT06867809 is a NA study of Spinal Cord Injury and Spinal Cord Injury Cervical that is actively recruiting participants, run by Jason Carmel. The registered enrollment target is 20 participants, below the 86-participant average among 99 other Spinal Cord Injury trials with a reported enrollment target (77% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06867809, a NA study of Spinal Cord Injury and Spinal Cord Injury Cervical, is actively recruiting participants, sponsored by Jason Carmel.

RECRUITING
Registry status
NA
Development phase
20 participants
Enrollment target
2
Study locations

Study Summary

Stimulation of the spinal cord and brain represents a new experimental therapy that may have potential to restore movement after spinal cord injury. While some scientists have begun to study the effect of electrical stimulation on patient's ability to walk and move their legs after lower spinal cord injury, the use of stimulation of the upper (cervical) spine to restore arm and hand function after cervical spinal cord injury remains less well explored. The investigators are doing this research study to improve understanding of whether cervical spinal cord stimulation and brain stimulation can be used to improve arm and hand function. To do this, the investigators will combine spine stimulation (in the form of electrical stimulation from electrical stimulation wires temporarily implanted next to the cervical spinal cord) and brain stimulation (in the form of transcranial magnetic stimulation). The investigators will perform a series of experiments over 29 days to study whether these forms of stimulation can be applied and combined to provide improvement in arm and hand function.

Primary Outcome

To assess safety of spinal cord stimulation and paired spine and brain stimulation for movement recovery after spinal cord injury, the investigators will record the number of serious adverse events related to the study device.

Interventions

  • DEVICE Epidural spinal cord stimulation and paired spine and brain stimulation

Study Locations (2)

New York

  • NewYork-Presbyterian Hospital / Columbia University Irving Medical Center (NYPH/CUIMC) - New York
  • NewYork-Presbyterian Allen Hospital / Columbia University Irving Medical Center (NYPH/CUIMC) - New York

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2026-01-15
Est. Completion 2027-03-31
Phase NA
Jason Carmel

1 total trials

What NCT06867809 shows while recruiting

NCT06867809 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 86-participant average among 99 other Spinal Cord Injury trials with a reported enrollment target (77% lower).

The record links to 2 conditions, with Spinal Cord Injury appearing as the primary indexed condition, and to 1 intervention - of which Epidural spinal cord stimulation and paired spine and brain stimulation is the first listed.

NCT06867809 reports a single indexed study location in New York.

Frequently Asked Questions

What is clinical trial NCT06867809 about?

NCT06867809 is a clinical study titled "Spine and Brain Stimulation for Movement Recovery After Cervical Spinal Cord Injury". Stimulation of the spinal cord and brain represents a new experimental therapy that may have potential to restore movement after spinal cord injury. While some scientists have begun to study the effect of electrical stimulation on patient's ability to walk and move their legs after lower spinal cord...

What is the current status of trial NCT06867809?

This trial is currently recruiting. It is a NA study. The enrollment target is 20 participants. The study started on 2026-01-15. Estimated completion is 2027-03-31.

What conditions does trial NCT06867809 study?

This clinical trial studies the following conditions: Spinal Cord Injury, Spinal Cord Injury Cervical.

What interventions are being tested in trial NCT06867809?

The interventions under investigation include: Epidural spinal cord stimulation and paired spine and brain stimulation (DEVICE).

Who is sponsoring clinical trial NCT06867809?

This trial is sponsored by Jason Carmel, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06867809 being conducted?

This trial has 2 study locations across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Spinal Cord Injury

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06867809's enrollment target sits among peer trials

20 55th of 99 higher than 41 of 99 other Spinal Cord Injury trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Spinal Cord Injury trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00573339 · 20 participants

    Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing

  • NCT00692939 · 20 participants · Phase 1

    Autologous Stem Cell Transplantation for Crohn's Disease

  • NCT00967785 · 20 participants · Phase 1

    A Phase I Study of Mozobil in the Treatment of Patients With WHIMS

  • NCT01406691 · 20 participants · Phase 4

    Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06867809, the US trial registry maintained by the National Library of Medicine. NCT06867809 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.